Investors eyeing the healthcare sector might find Myriad Genetics, Inc. (NASDAQ: MYGN) a compelling yet complex prospect. As a leader in molecular diagnostic testing and precision medicine, Myriad’s portfolio offers..
AngioDynamics, Inc. (ANGO), a key player in the healthcare sector, is drawing significant attention from individual investors, thanks to a compelling 43.85% upside potential as suggested by the average target..
Emergent BioSolutions Inc. (NYSE: EBS) presents an intriguing opportunity for investors, particularly in the healthcare sector. With a current market capitalization of $625.27 million, this Gaithersburg, Maryland-based company operates within..
Prothena Corporation plc (PRTA), a prominent player in the biotechnology sector, has been making waves with its innovative approaches to treating neurodegenerative diseases. Based in Dublin, Ireland, this late-stage clinical..
Rapport Therapeutics, Inc. (NASDAQ: RAPP), a promising player in the biotechnology sector, has been catching the eye of investors with its ambitious approach to treating central nervous system (CNS) disorders...
Abivax SA (ABVX) has captured the attention of investors with a remarkable ascent to its current price of $133.09, marking the peak of its 52-week range, which started at a..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a prominent player in the biotechnology sector, specializing in cell programming. Despite its innovative approach and diversified services across various industries, Ginkgo Bioworks..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biotechnology company dedicated to advancing treatments for serious retinal diseases, presents a captivating opportunity for investors, particularly given the company’s projected potential upside of..
Celcuity Inc. (CELC), a promising player in the biotechnology sector, is catching the attention of investors following its recent surge in market activity. With a market capitalization of $4.66 billion,..
Standard BioTools Inc. (NASDAQ: LAB) presents an intriguing case for investors interested in the healthcare sector, specifically within medical devices. Headquartered in South San Francisco, California, the company is emerging..
Surmodics, Inc. (NASDAQ: SRDX) is a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Eden Prairie, Minnesota, the company focuses on performance coating technologies..
MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors with its potential for significant upside, as suggested by a 215% increase in target price. This clinical-stage genetics medicine..
Bioventus Inc. (BVS), a notable player in the healthcare sector, provides innovative medical devices aimed at relieving pain and addressing musculoskeletal therapies. With a market capitalization of $496.97 million, Bioventus..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is catching the eye of investors in the healthcare sector, particularly those with an interest in biotechnology. Founded in 2019 and based in New York,..
Personalis, Inc. (PSNL), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, offers a suite of cutting-edge cancer genomic tests and services. Headquartered in Fremont,..
Septerna, Inc. (SEPN) is capturing the attention of investors in the biotechnology sector with its remarkable 12,113.10% revenue growth and a potential 11.60% upside, according to analysts. As a clinical-stage..
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, has captured investor interest with its ambitious pipeline and substantial potential upside. Specializing in treatments for obesity, metabolic, and liver diseases, Altimmune’s lead..
Atai Beckley N.V. (NASDAQ: ATAI) emerges as a compelling investment opportunity within the biotechnology sector, particularly for investors keen on the burgeoning field of mental health treatments. Headquartered in Amstelveen,..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making significant waves in the biotechnology sector, particularly for investors seeking exposure to transformative immunology-based therapies. With an impressive market capitalization of $2.16 billion,..
